helenalin has been researched along with cycloheximide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TM; Balzarini, J; De Clercq, E; Dimmock, JR; Kandepu, NM; Kowalchuk, TP; LeClerc, R; Motaganahalli, NL; Nazarali, AJ; Prisciak, JS; Pugazhenthi, U; Quail, JW; Santos, CL | 1 |
Doody, GM; Stephenson, S; Tooze, RM | 1 |
2 other study(ies) available for helenalin and cycloheximide
Article | Year |
---|---|
Sequential cytotoxicity: a theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones and related compounds.
Topics: Animals; Antineoplastic Agents; Apoptosis; Crystallography, X-Ray; Cyclohexanones; Drug Screening Assays, Antitumor; Humans; Mannich Bases; Mice; Models, Molecular; Neoplasm Proteins; RNA, Neoplasm; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response.
Topics: Animals; B-Lymphocytes; Cycloheximide; Dithiothreitol; DNA-Binding Proteins; eIF-2 Kinase; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; HeLa Cells; HL-60 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; Nuclear Proteins; Positive Regulatory Domain I-Binding Factor 1; Protein Folding; Protein Synthesis Inhibitors; Regulatory Factor X Transcription Factors; Repressor Proteins; RNA, Messenger; Sesquiterpenes; Sesquiterpenes, Guaiane; Signal Transduction; Thapsigargin; Transcription Factors | 2006 |